Description

Bromazolam 2.2 mg

Bromazolam 2.2mg is a specific dosage of bromazolam, a synthetic triazolobenzodiazepine with a chemical structure similar to other benzodiazepines. But bromazolam is not an FDA approved medicine for therapeutic use in the U.S. Limited clinical information is available in humans. People should not use a product labelled “Bromazolam 2.2 mg” as an approved prescription dosage.

What Is Bromazolam?

Bromazolam is a member of the benzodiazepine family of drugs. These agents may induce CNS depression, sedation and decreased alertness. Bromazolam has been detected in illicit and counterfeit tablet markets where it can be sold as or misrepresented as another benzodiazepine. Thus the name or strength printed on a tablet may not be a reliable description of what the product actually contains.

Bromazolam does not have an established FDA-approved therapeutic dosing schedule, unlike approved benzodiazepines. As such, there is no FDA-approved medical guideline that specifies Bromazolam 2.2 mg as a standard therapeutic dose.

Potential Effects of Bromazolam

Bromazolam may cause sedation similar to other benzodiazepine-type drugs. It can cause people to become drowsy, uncoordinated, less alert, confused, or have trouble with normal judgement. Effects can vary, however, as human clinical research is limited and illicit products may contain unknown substances.

Severe intoxication can also lead to serious medical complications. The CDC said in cases involving bromazolam, patients developed seizures, hyperthermia and myocardial injury after taking tablets they thought contained alprazolam.

Bromazolam 2.2 mg and Safety

The number “2.2 mg” should not be construed as evidence that a product is safe, medically appropriate or properly labelled. In unregulated markets, counterfeit tablets may contain different active ingredients or combinations of substances. That adds another risk, in that the person may not know what was actually taken.

Benzodiazepine-type drugs may also cause problems with dependence, misuse and withdrawal. “The FDA warns that benzodiazepines as a drug class may be linked to abuse, addiction, physical dependence and possibly life-threatening withdrawal reactions.” Combining opioids with other central nervous system depressants can also increase the risk of deep sedation and breathing problems.

Why Combining Substances Is Risky

Combining sedatives can increase impairment and may make an overdose more difficult to detect; This is especially true for benzodiazepines and opioids which can have an additive effect on the central nervous system. FDA specifically warns of serious sedation and respiratory depression when benzodiazepines are combined with opioids.

Therefore, anyone who suspects an overdose or severe reaction should seek emergency medical attention immediately and not wait for symptoms to go away.

Recognising a Severe Reaction

The warning signs can be extreme sleepiness, inability to wake the person, severe confusion, loss of coordination, seizures, abnormal body temperature or difficulty breathing. Serious complications and need for hospital treatment were reported in bromazolam cases.

If a person loses consciousness, has a seizure or is having trouble breathing after suspected exposure to bromazolam, call local emergency services immediately.

Bromazolam 2.2 mg – Frequently Asked Questions

Is Bromazolam 2.2 mg an FDA approved medicine?

No FDA information indicates that there is no FDA-approved version of bromazolam for therapeutic use in the United States.

Is 2.2 mg a regular medical dose?

Bromazolam does not have an approved therapeutic dosing schedule and 2.2 mg is not a standard medical dose. Products with this label are not necessarily predictable or medically validated for potency.

Bromazolam is similar to other benzodiazepines.

Yes. The CDC has documented cases in which people consumed bromazolam after believing counterfeit tablets were alprazolam.

What should someone do after a suspected overdose?

If there is unconsciousness, trouble breathing, seizures, or very severe confusion, call emergency medical services right away.

Abstract

It would be more accurate to describe Bromazolam 2.2 mg as a labelled quantity of an unapproved benzodiazepine-related compound rather than as a usual prescription drug. Because little research has been done in humans, and counterfeit products can contain unexpected substances, it can be difficult to predict the risks. Therefore, it is vital to correctly identify the problem and seek immediate medical advice and emergency treatment for serious symptoms.